Cargando…

Interferon-γ Autoantibodies as Predisposing Factor for Nontuberculous Mycobacterial Infection

Detalles Bibliográficos
Autores principales:	Valour, Florent, Perpoint, Thomas, Sénéchal, Agathe, Kong, Xiao-Fei, Bustamante, Jacinta, Ferry, Tristan, Chidiac, Christian, Ader, Florence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2016
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4880074/ https://www.ncbi.nlm.nih.gov/pubmed/27192204 http://dx.doi.org/10.3201/eid2206.151860

Ejemplares similares

A retrospective study of factors associated with treatment decision for nontuberculous mycobacterial lung disease in adults without altered systemic immunity
por: Provoost, Judith, et al.
Publicado: (2018)

Disseminated Nontuberculous Mycobacterial Infection Associated With Acquired Immunodeficiency Due to Anti–Interferon γ Autoantibodies
por: Yerramilli, Arvind, et al.
Publicado: (2019)

Clinical Presentation, Diagnosis, and Bacterial Epidemiology of Peritoneal Tuberculosis in Two University Hospitals in France
por: Cavalli, Zoé, et al.
Publicado: (2016)

Treatment Dilemmas in Disseminated Nontuberculous Mycobacterial Infections With Interferon-gamma Autoantibodies
por: King, Elizabeth M, et al.
Publicado: (2021)

Pubic Osteomyelitis: Epidemiology and Factors Associated with Management Failure in Two French Reference Centers
por: Ferry, Tristan, et al.
Publicado: (2017)

Actinomycosis: etiology, clinical features, diagnosis, treatment, and management
por: Valour, Florent, et al.
Publicado: (2014)

Daptomycin > 6 mg/kg/day as salvage therapy in patients with complex bone and joint infection: cohort study in a regional reference center
por: Roux, Sandrine, et al.
Publicado: (2016)

Clinical manifestations, course, and outcome of patients with neutralizing anti-interferon-γ autoantibodies and disseminated nontuberculous mycobacterial infections
por: Chi, Chih-Yu, et al.
Publicado: (2016)

Bortezomib treatment for refractory nontuberculous mycobacterial infection in the setting of interferon gamma autoantibodies
por: Rocco, Joseph M., et al.
Publicado: (2021)

Determinants of methicillin-susceptible Staphylococcus aureusnative bone and joint infection treatment failure: a retrospective cohort study
por: Valour, Florent, et al.
Publicado: (2014)

Impact of anti-inflammatory drug consumption in peritonsillar abscesses: a retrospective cohort study
por: Feasson, Thomas, et al.
Publicado: (2016)

Factors associated with acquired Anti IFN- γ autoantibody in patients with nontuberculous mycobacterial infection
por: Phoompoung, Pakpoom, et al.
Publicado: (2017)

Nontuberculous Mycobacterial Infection Predisposing to Chronic Cavitary Pulmonary Aspergillosis
por: Vera Nieves, Bryan, et al.
Publicado: (2021)

La négativité persistante des prélèvements nasopharyngés est-elle fiable pour éliminer une pneumonie au SARS-CoV-2 chez un patient en quarantaine post-exposition ?
por: Benech, N., et al.
Publicado: (2020)

Differential Impairment of Interferon-γ Responses in Two Cases of Pulmonary Nontuberculous Mycobacterial Disease
por: Rae, William, et al.
Publicado: (2016)

Sputum Detection of Predisposing Genetic Mutations in Women with Pulmonary Nontuberculous Mycobacterial Disease
por: Philley, Julie V., et al.
Publicado: (2018)

Anti-interferon-γ Antibody-seropositive Disseminated Nontuberculous Mycobacterial Infection Mimicking POEMS and TAFRO Syndromes
por: Hidekawa, Chiharu, et al.
Publicado: (2022)

1355. Efficacy and Tolerability of Linezolid Adjunctive Treatment for Nontuberculous Mycobacterial Infection in Patients with Acquired Anti-Interferon-Gamma Autoantibody
por: Chavapradit, Natthakit, et al.
Publicado: (2019)

Pseudomonas aeruginosa Implant-Associated Bone and Joint Infections: Experience in a Regional Reference Center in France
por: Cerioli, Matteo, et al.
Publicado: (2020)

Corynebacterium Bone and Joint Infection (BJI): A Retrospective Cohort Study in a Reference Center for BJI Management
por: Ferry, Tristan, et al.
Publicado: (2017)

Linezolid in the Starter Combination for Multidrug-Resistant Tuberculosis: Time to Move on to Group Four?
por: Grard, Soazic, et al.
Publicado: (2015)

Nontuberculous mycobacterial osteomyelitis
por: Bi, Sheng, et al.
Publicado: (2015)

Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administration
por: Peeters, Olivier, et al.
Publicado: (2016)

Relationship between discordant response to HAART, Tregs, immune activation and low-level viraemia
por: Saison, Julien, et al.
Publicado: (2014)

Recurrent Nontuberculous Mycobacterial Tenosynovitis
por: Kwan, Melissa, et al.
Publicado: (2021)

Profiling mycobacterial communities in pulmonary nontuberculous mycobacterial disease
por: Cowman, Steven A., et al.
Publicado: (2018)

Prolonged Cefoxitin Infusion Using Mobile Elastomeric Infusors In Outpatients With Bone And Joint Infection
por: Cavalli, Zoé, et al.
Publicado: (2018)

Pressure ulcer-related pelvic osteomyelitis: evaluation of a two-stage surgical strategy (debridement, negative pressure therapy and flap coverage) with prolonged antimicrobial therapy
por: Andrianasolo, Johan, et al.
Publicado: (2018)

Pressure Ulcer-Related Pelvic Osteomyelitis: Evaluation of a Two-Stage Surgical Strategy (Debridement, Negative Pressure Therapy and Flap Coverage) with Prolonged Antimicrobial Therapy
por: Ferry, Tristan, et al.
Publicado: (2017)

Disseminated nontuberculous mycobacterial infection with multifocal retinitis and vasculitis in an immunocompromised patient with anti-IFN-ɣ autoantibodies
por: Lee, Tian Loon, et al.
Publicado: (2016)

Molecular assessment of mycobacterial burden in the treatment of nontuberculous mycobacterial disease
por: Ellis, Huw C., et al.
Publicado: (2023)

Management of pulmonary nontuberculous mycobacterial disease
por: Horan, Kathleen L, et al.
Publicado: (2009)

Treatment of Extrapulmonary Nontuberculous Mycobacterial Diseases
por: Wi, Yu Mi
Publicado: (2019)

Correction of Linezolid-Induced Myelotoxicity After Switch to Tedizolid in a Patient Requiring Suppressive Antimicrobial Therapy for Multidrug-Resistant Staphylococcus epidermidis Prosthetic-Joint Infection
por: Ferry, Tristan, et al.
Publicado: (2018)

Functional neutralization of anti-IFN-γ autoantibody in patients with nontuberculous mycobacteria infection
por: Krisnawati, Dyah Ika, et al.
Publicado: (2019)

The performance of interferon-gamma release assay in nontuberculous mycobacterial diseases: a retrospective study in China
por: Wang, Mao-Shui, et al.
Publicado: (2016)

The Impact of Nontuberculous Mycobacteria Species on Mortality in Patients With Nontuberculous Mycobacterial Lung Disease
por: Wang, Ping-Huai, et al.
Publicado: (2022)

Nontuberculous Mycobacterial Pulmonary Diseases in Immunocompetent Patients
por: Koh, Won-Jung, et al.
Publicado: (2002)

Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease
por: Kwon, Yong-Soo, et al.
Publicado: (2016)

Extrapulmonary Nontuberculous Mycobacterial Infections in Southern Arizona
por: Florita, Catalin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_meer73oqj136b4vocvbl4sot1s